Anti-EGFR Antibody (D2C7) is a monoclonal antibody targeting EGFR. The recombinant immunotoxin D2C7-(scdsFv)-PE38KDEL, developed from Anti-EGFR Antibody (D2C7), exhibits antitumor activity in glioblastoma models.
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted